Annual Long Term Debt
$23.22 B
-$468.00 M-1.98%
31 December 2023
Summary:
AstraZeneca annual long term debt is currently $23.22 billion, with the most recent change of -$468.00 million (-1.98%) on 31 December 2023. During the last 3 years, it has risen by +$5.23 billion (+29.05%). AZN annual long term debt is now -19.61% below its all-time high of $28.89 billion, reached on 31 December 2021.AZN Long Term Debt Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Long Term Debt
$29.99 B
+$1.82 B+6.45%
30 September 2024
Summary:
AstraZeneca quarterly long term debt is currently $29.99 billion, with the most recent change of +$1.82 billion (+6.45%) on 30 September 2024. Over the past year, it has increased by +$7.02 billion (+30.58%). AZN quarterly long term debt is now at all-time high.AZN Quarterly Long Term Debt Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
AZN Long Term Debt Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -2.0% | +30.6% |
| 3 y3 years | +29.1% | +3.6% |
| 5 y5 years | +33.8% | +70.6% |
AZN Long Term Debt High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | -19.6% | +29.1% | at high | +30.6% |
| 5 y | 5 years | -19.6% | +43.2% | at high | +92.1% |
| alltime | all time | -19.6% | >+9999.0% | at high | >+9999.0% |
AstraZeneca Long Term Debt History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $29.99 B(+6.5%) |
| June 2024 | - | $28.17 B(-0.2%) |
| Mar 2024 | - | $28.22 B(+21.5%) |
| Dec 2023 | $23.22 B(-2.0%) | $23.22 B(+1.1%) |
| Sept 2023 | - | $22.97 B(-8.3%) |
| June 2023 | - | $25.05 B(-9.4%) |
| Mar 2023 | - | $27.65 B(+16.7%) |
| Dec 2022 | $23.69 B(-18.0%) | $23.69 B(+0.0%) |
| Sept 2022 | - | $23.68 B(-12.8%) |
| June 2022 | - | $27.15 B(-5.8%) |
| Mar 2022 | - | $28.80 B(-0.3%) |
| Dec 2021 | $28.89 B(+60.5%) | $28.89 B(-0.2%) |
| Sept 2021 | - | $28.94 B(+17.6%) |
| June 2021 | - | $24.60 B(+37.6%) |
| Mar 2021 | - | $17.87 B(-0.7%) |
| Dec 2020 | $17.99 B(+11.0%) | $17.99 B(-4.1%) |
| Sept 2020 | - | $18.75 B(+20.1%) |
| June 2020 | - | $15.62 B(-3.0%) |
| Mar 2020 | - | $16.11 B(-0.7%) |
| Dec 2019 | $16.22 B(-6.6%) | $16.22 B(-7.8%) |
| Sept 2019 | - | $17.58 B(-1.6%) |
| June 2019 | - | $17.87 B(+0.1%) |
| Mar 2019 | - | $17.86 B(+2.9%) |
| Dec 2018 | $17.36 B(+11.6%) | $17.36 B(-5.8%) |
| Sept 2018 | - | $18.42 B(+19.2%) |
| June 2018 | - | $15.45 B(-1.5%) |
| Mar 2018 | - | $15.68 B(+0.8%) |
| Dec 2017 | $15.56 B(+7.3%) | $15.56 B(-8.0%) |
| Sept 2017 | - | $16.91 B(+0.7%) |
| June 2017 | - | $16.79 B(+15.3%) |
| Mar 2017 | - | $14.56 B(+0.4%) |
| Dec 2016 | $14.50 B(+2.6%) | $14.50 B(-1.6%) |
| Sept 2016 | - | $14.74 B(-10.7%) |
| June 2016 | - | $16.52 B(+16.8%) |
| Mar 2016 | - | $14.14 B(+0.0%) |
| Dec 2015 | $14.14 B(+68.4%) | $14.14 B(+70.8%) |
| Sept 2015 | - | $8.28 B(-0.3%) |
| June 2015 | - | $8.30 B(+0.4%) |
| Mar 2015 | - | $8.27 B(-1.5%) |
| Dec 2014 | $8.40 B(-2.2%) | $8.40 B(+11.6%) |
| Sept 2014 | - | $7.53 B(-0.6%) |
| June 2014 | - | $7.57 B(+0.3%) |
| Mar 2014 | - | $7.55 B(-12.1%) |
| Dec 2013 | $8.59 B(-8.7%) | $8.59 B(+0.3%) |
| Sept 2013 | - | $8.57 B(+0.7%) |
| June 2013 | - | $8.51 B(-8.7%) |
| Mar 2013 | - | $9.32 B(-0.9%) |
| Dec 2012 | $9.41 B(+28.2%) | $9.41 B(+0.7%) |
| Sept 2012 | - | $9.35 B(+27.9%) |
| June 2012 | - | $7.31 B(-0.9%) |
| Mar 2012 | - | $7.38 B(+0.5%) |
| Dec 2011 | $7.34 B | $7.34 B(-0.8%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2011 | - | $7.39 B(-19.7%) |
| June 2011 | - | $9.21 B(-3.4%) |
| Mar 2011 | - | $9.53 B(+4.8%) |
| Dec 2010 | $9.10 B(-0.4%) | $9.10 B(-4.5%) |
| Sept 2010 | - | $9.53 B(+4332.6%) |
| June 2010 | - | $215.00 M(-97.7%) |
| Mar 2010 | - | $9.29 B(+1.7%) |
| Dec 2009 | $9.14 B(+6032.2%) | $9.14 B(-13.2%) |
| Sept 2009 | - | $10.52 B(+2.0%) |
| June 2009 | - | $10.32 B(+1.8%) |
| Mar 2009 | - | $10.14 B(+6704.7%) |
| Dec 2008 | $149.00 M(-98.6%) | $149.00 M(-98.6%) |
| Sept 2008 | - | $10.83 B(-1.9%) |
| June 2008 | - | $11.03 B(-0.8%) |
| Mar 2008 | - | $11.12 B(+2.2%) |
| Dec 2007 | $10.88 B(+900.6%) | $10.88 B(+20.9%) |
| Sept 2007 | - | $8.99 B(+750.9%) |
| June 2007 | - | $1.06 B(-2.8%) |
| Mar 2007 | - | $1.09 B(0.0%) |
| Dec 2006 | $1.09 B(-2.2%) | $1.09 B(-0.2%) |
| Sept 2006 | - | $1.09 B(+4.1%) |
| June 2006 | - | $1.05 B(-3.8%) |
| Mar 2006 | - | $1.09 B(-2.2%) |
| Dec 2005 | $1.11 B(-1.4%) | $1.11 B(-1.0%) |
| Sept 2005 | - | $1.12 B(-3.5%) |
| June 2005 | - | $1.16 B(+4.7%) |
| Mar 2005 | - | $1.11 B(-1.4%) |
| Dec 2004 | $1.13 B(+271.9%) | $1.13 B(+2.9%) |
| Sept 2004 | - | $1.09 B(-0.2%) |
| June 2004 | - | $1.10 B(+259.7%) |
| Mar 2004 | - | $305.00 M(+0.7%) |
| Dec 2003 | $303.00 M(-7.6%) | $303.00 M(-6.5%) |
| June 2003 | - | $323.90 M(-1.3%) |
| Dec 2002 | $328.00 M(-48.3%) | $328.00 M(-3.2%) |
| June 2002 | - | $338.92 M(-46.6%) |
| Dec 2001 | $635.00 M(+0.5%) | $635.00 M(-1.2%) |
| June 2001 | - | $642.71 M(+1.7%) |
| Dec 2000 | $631.80 M(-14.6%) | $631.80 M(-15.7%) |
| June 2000 | - | $749.10 M(+1.2%) |
| Dec 1999 | $740.00 M(-2.8%) | $740.00 M(-0.1%) |
| Sept 1999 | - | $741.00 M(-1.1%) |
| June 1999 | - | $749.00 M(-1.6%) |
| Dec 1998 | $761.00 M(-11.8%) | $761.00 M(-9.7%) |
| June 1998 | - | $843.00 M(-2.3%) |
| Dec 1997 | $862.92 M(+2.0%) | $862.92 M(+2.0%) |
| Dec 1996 | $845.98 M(-0.5%) | $845.98 M(-0.5%) |
| Dec 1995 | $849.87 M(+3.3%) | $849.87 M(-3.1%) |
| June 1995 | - | $877.00 M(+6.6%) |
| Dec 1994 | $822.35 M(-0.9%) | $822.35 M(-0.9%) |
| Dec 1993 | $829.83 M(-39.5%) | $829.83 M |
| Dec 1992 | $1.37 B(-57.5%) | - |
| Dec 1991 | $3.23 B(-2.3%) | - |
| Dec 1990 | $3.30 B | - |
FAQ
- What is AstraZeneca annual long term debt?
- What is the all time high annual long term debt for AstraZeneca?
- What is AstraZeneca annual long term debt year-on-year change?
- What is AstraZeneca quarterly long term debt?
- What is the all time high quarterly long term debt for AstraZeneca?
- What is AstraZeneca quarterly long term debt year-on-year change?
What is AstraZeneca annual long term debt?
The current annual long term debt of AZN is $23.22 B
What is the all time high annual long term debt for AstraZeneca?
AstraZeneca all-time high annual long term debt is $28.89 B
What is AstraZeneca annual long term debt year-on-year change?
Over the past year, AZN annual long term debt has changed by -$468.00 M (-1.98%)
What is AstraZeneca quarterly long term debt?
The current quarterly long term debt of AZN is $29.99 B
What is the all time high quarterly long term debt for AstraZeneca?
AstraZeneca all-time high quarterly long term debt is $29.99 B
What is AstraZeneca quarterly long term debt year-on-year change?
Over the past year, AZN quarterly long term debt has changed by +$7.02 B (+30.58%)